Literature DB >> 17998718

Serous papillary adenocarcinoma of the rete testis: unusual ultrasonography and pathological findings.

Wilmosh Mermershtain1, Neta Vardi, Irina Gusakova, Josef Klein.   

Abstract

We report a case of serous papillary adenocarcinoma of the rete testis in a 22-year-old man. Adenocarcinoma of the rete testis is highly resistant to radiotherapy and any known chemotherapeutic regimen. We recommend radical orchiectomy At last follow up, the patient was well, without any evidence of recurrence, ten years after surgery.

Entities:  

Mesh：

Year:  2007        PMID： 17998718     DOI： 10.4103/0973-1482.31970

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN： 1998-4138            Impact factor:   1.805


  6 in total

1.  High Grade Serous Cystadenocarcinoma of Testis-Case Report of a Rare Ovarian Epithelial Type Tumour.

Authors:  Sithara Aravind; Sangeetha K Nayanar; R Varadharajaperumal; T V Satheeshbabu; Satheesan Balasubramanian
Journal:  J Clin Diagn Res       Date:  2017-06-01

2.  Metastatic serous carcinoma of the testis: a case report and review of the literature.

Authors:  Yuk Ting Ma; Shalini Chaudhri; Michael H Cullen
Journal:  Case Rep Oncol       Date:  2011-04-18

3.  Testicular papillary serous cystadenocarcinoma: a rare case report and review of the literature.

Authors:  Bita Geramizadeh; Mohammad Reza Farzaneh; Sara Pakbaz; Shahriar Zeighami
Journal:  Rare Tumors       Date:  2011-12-23

4.  Primary adenocarcinoma of the rete testis: A case report and review of the literature.

Authors:  Ye Tian; Wenqing Yao; Lulu Yang; Jianzhong Wang; Romel Wazir; Kunjie Wang
Journal:  Oncol Lett       Date:  2013-11-26       Impact factor: 2.967

5.  Primary adenocarcinoma of rete testis with distinct biphasic pattern: An extremely rare entity and diagnostic challenge.

Authors:  Prithwijit Ghosh; Kaushik Saha
Journal:  J Nat Sci Biol Med       Date:  2015 Jan-Jun

6.  KMT2C mutation in a Chinese man with primary multidrug-resistant metastatic adenocarcinoma of rete testis: a case report.

Authors:  Yue Zhang; Xiaoyan He; Hui Gao
Journal:  BMC Urol       Date:  2022-08-09       Impact factor: 2.090
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.